NRIP Inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of the NRIP (Nuclear Receptor Interacting Protein) gene. The NRIP gene encodes a protein that plays a significant role in interacting with nuclear receptors, which are critical regulators of gene expression. NRIP is involved in multiple cellular processes, particularly in the regulation of transcriptional activity and the coordination of cellular responses to external signals. The interaction of NRIP with nuclear receptors influences various signaling pathways, modulating cellular functions like growth, differentiation, and metabolism. NRIP Inhibitors work by binding to key domains within the NRIP protein, thereby interfering with its ability to interact with nuclear receptors and other associated proteins. This modulation affects downstream gene expression, altering the activity of pathways controlled by NRIP.
The precise targeting of NRIP Inhibitors provides researchers with a valuable tool to study the complex network of transcriptional regulation mediated by nuclear receptors. By inhibiting NRIP's interaction with these receptors, scientists can gain insight into the gene expression patterns that are influenced by this interaction. Additionally, NRIP's role in coordinating signal transduction between the cell's external environment and its transcriptional machinery makes these inhibitors useful for exploring how cells adapt to changing conditions. NRIP Inhibitors can serve as powerful research tools for investigating the molecular mechanisms behind cellular regulation, particularly in the context of nuclear receptor signaling. The study of these inhibitors may shed light on the broader role that NRIP plays in coordinating cellular responses, providing important insights into the regulation of gene expression and cellular communication.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Selective Estrogen Receptor Modulator (SERM), could indirectly affect NRIP through estrogen receptor pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another PPARγ agonist, may affect transcriptional regulation involving NRIP. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, can affect chromatin structure and thereby influence NRIP-mediated regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, potentially affecting gene expression and thus influencing NRIP. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Influences gene expression through the vitamin D receptor, could impact NRIP function. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Glucocorticoid and progesterone receptor antagonist, could influence NRIP-related pathways. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Endocrine disruptor, potentially affecting NRIP through estrogenic pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Influences various signaling pathways, could indirectly modulate NRIP function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Phytoestrogen, known to modulate gene expression, potentially affecting NRIP. | ||||||